299 related articles for article (PubMed ID: 23835434)
1. The secretome of colon cancer stem cells contains drug-metabolizing enzymes.
Emmink BL; Verheem A; Van Houdt WJ; Steller EJ; Govaert KM; Pham TV; Piersma SR; Borel Rinkes IH; Jimenez CR; Kranenburg O
J Proteomics; 2013 Oct; 91():84-96. PubMed ID: 23835434
[TBL] [Abstract][Full Text] [Related]
2. Secretome protein signature of human pancreatic cancer stem-like cells.
Brandi J; Dalla Pozza E; Dando I; Biondani G; Robotti E; Jenkins R; Elliott V; Park K; Marengo E; Costello E; Scarpa A; Palmieri M; Cecconi D
J Proteomics; 2016 Mar; 136():1-12. PubMed ID: 26850699
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target.
Van Houdt WJ; Emmink BL; Pham TV; Piersma SR; Verheem A; Vries RG; Fratantoni SA; Pronk A; Clevers H; Borel Rinkes IH; Jimenez CR; Kranenburg O
Mol Cell Proteomics; 2011 Dec; 10(12):M111.011353. PubMed ID: 21788403
[TBL] [Abstract][Full Text] [Related]
4. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
[TBL] [Abstract][Full Text] [Related]
5. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Kim D; Choi BH; Ryoo IG; Kwak MK
Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
[TBL] [Abstract][Full Text] [Related]
6. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
[TBL] [Abstract][Full Text] [Related]
8. Human colonic fibroblasts regulate stemness and chemotherapy resistance of colon cancer stem cells.
Colak S; Medema JP
Cell Cycle; 2016 Jun; 15(12):1531-7. PubMed ID: 25483065
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
10. Comparison of EpCAM
Liu M; Di J; Liu Y; Su Z; Jiang B; Wang Z; Su X
Cancer Biol Ther; 2018; 19(10):939-947. PubMed ID: 29580161
[TBL] [Abstract][Full Text] [Related]
11. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
12. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
13. Sulindac modulates secreted protein expression from LIM1215 colon carcinoma cells prior to apoptosis.
Greening DW; Ji H; Kapp EA; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2293-307. PubMed ID: 23899461
[TBL] [Abstract][Full Text] [Related]
14. CD10
Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
[TBL] [Abstract][Full Text] [Related]
15. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
16. Triptolide inhibits CD133
Acikgoz E; Tatar C; Oktem G
J Cell Biochem; 2020 Jun; 121(5-6):3313-3324. PubMed ID: 31904143
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
Tan S; Yamashita A; Gao SJ; Kurisawa M
Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
[TBL] [Abstract][Full Text] [Related]
18. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity.
Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T
Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
